BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23472998)

  • 1. Endotherapy for superficial adenocarcinoma of the esophagus: an American experience.
    Saligram S; Chennat J; Hu H; Davison JM; Fasanella KE; McGrath K
    Gastrointest Endosc; 2013 Jun; 77(6):872-6. PubMed ID: 23472998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR; Hagen JA; Ayazi S; Augustin F; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):39-47. PubMed ID: 21055772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units.
    Cameron GR; Jayasekera CS; Williams R; Macrae FA; Desmond PV; Taylor AC
    Gastrointest Endosc; 2014 Dec; 80(6):971-83.e1. PubMed ID: 24929493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of EMR to completely remove Barrett's esophagus: experience in 41 patients.
    Gerke H; Siddiqui J; Nasr I; Van Handel DM; Jensen CS
    Gastrointest Endosc; 2011 Oct; 74(4):761-71. PubMed ID: 21824611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma.
    Bahin FF; Jayanna M; Hourigan LF; Lord RV; Whiteman D; Williams SJ; Lee EY; Bourke MJ
    Gastrointest Endosc; 2016 Jan; 83(1):68-77. PubMed ID: 26096759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, randomized, controlled trial of confocal laser endomicroscopy assessment of residual metaplasia after mucosal ablation or resection of GI neoplasia in Barrett's esophagus.
    Wallace MB; Crook JE; Saunders M; Lovat L; Coron E; Waxman I; Sharma P; Hwang JH; Banks M; DePreville M; Galmiche JP; Konda V; Diehl NN; Wolfsen HC
    Gastrointest Endosc; 2012 Sep; 76(3):539-47.e1. PubMed ID: 22749368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia.
    Chevaux JB; Piessevaux H; Jouret-Mourin A; Yeung R; Danse E; Deprez PH
    Endoscopy; 2015 Feb; 47(2):103-12. PubMed ID: 25412090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
    Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
    Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center.
    Kaul V; Bittner K; Ullah A; Kothari S
    Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31909783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective.
    Sengupta N; Ketwaroo GA; Bak DM; Kedar V; Chuttani R; Berzin TM; Sawhney MS; Pleskow DK
    Gastrointest Endosc; 2015 Sep; 82(3):443-8. PubMed ID: 25887715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotherapy in case of relapse of neoplastic Barrett's esophagus after successful initial endoscopic resection.
    Godat S; Caillol F; Autret A; Bories E; Pesenti C; Ratone JP; De Cassan C; Poizat F; Giovannini M
    Surg Endosc; 2017 Sep; 31(9):3703-3710. PubMed ID: 28078459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directional distribution of neoplasia in Barrett's esophagus is not influenced by distance from the gastroesophageal junction.
    Cassani L; Sumner E; Slaughter JC; Yachimski P
    Gastrointest Endosc; 2013 Jun; 77(6):877-82. PubMed ID: 23528657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients.
    Schmidt HM; Mohiuddin K; Bodnar AM; El Lakis M; Kaplan S; Irani S; Gan I; Ross A; Low DE
    Surg Endosc; 2016 Aug; 30(8):3391-401. PubMed ID: 26541725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
    Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
    Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.